Northern Trust’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$415K Hold
107,011
﹤0.01% 3687
2025
Q4
$209K Sell
107,011
-10,825
-9% -$17.8K ﹤0.01% 3975
2025
Q3
$99.6K Sell
117,836
-30,631
-21% -$22.5K ﹤0.01% 4140
2025
Q2
$108K Sell
148,467
-342,587
-70% -$257K ﹤0.01% 4095
2025
Q1
$423K Buy
491,054
+16,233
+3% +$24.1K ﹤0.01% 3640
2024
Q4
$798K Sell
474,821
-32,695
-6% -$78.2K ﹤0.01% 3483
2024
Q3
$1.45M Buy
507,516
+11,146
+2% +$28.8K ﹤0.01% 3181
2024
Q2
$1.16M Sell
496,370
-17,906
-3% -$46.8K ﹤0.01% 3176
2024
Q1
$1.51M Sell
514,276
-19,541
-4% -$55.4K ﹤0.01% 3108
2023
Q4
$1.6M Sell
533,817
-501
-0.1% -$1.43K ﹤0.01% 3112
2023
Q3
$1.69M Sell
534,318
-949
-0.2% -$3.09K ﹤0.01% 3030
2023
Q2
$2.07M Buy
535,267
+90,202
+20% +$260K ﹤0.01% 2985
2023
Q1
$1.23M Buy
445,065
+1,475
+0.3% +$3.09K ﹤0.01% 3150
2022
Q4
$798K Sell
443,590
-1,784
-0.4% -$3.44K ﹤0.01% 3344
2022
Q3
$945K Sell
445,374
-4,224
-0.9% -$10.6K ﹤0.01% 3319
2022
Q2
$1.21M Buy
449,598
+309,274
+220% +$1.15M ﹤0.01% 3289
2022
Q1
$609K Sell
140,324
-4,023
-3% -$16.5K ﹤0.01% 3663
2021
Q4
$748K Buy
144,347
+53,763
+59% +$288K ﹤0.01% 3656
2021
Q3
$556K Buy
+90,584
New +$722K ﹤0.01% 3728

Other funds holding NAUT

Northern Trust's NAUT Position: Q1 2026 in Review

Northern Trust held its Nautilus Biotechnolgy (NAUT) position steady in Q1 2026 at 107,011 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #3687.

Northern Trust first reported a position in NAUT in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.07M in Q2 2023. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Northern Trust held 107,011 shares of Nautilus Biotechnolgy worth $415K as of Q1 2026.
  • Northern Trust left its Nautilus Biotechnolgy share count unchanged in Q1 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3687 holding.
  • Northern Trust first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 19 quarters since.
  • Northern Trust's Nautilus Biotechnolgy position peaked at $2.07M in Q2 2023.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.